collected by :Molly Tony
The Wall Street Journal brings news that President Trump and HHS Secretary Price have chosen to nominate Scott Gottlieb to be the next commissioner of the Food and Drug Administration.
More important, he knows how it could do a better job.
Gottlieb is the epitome of a constructive critic of the agency he has been nominated to lead.
Gottlieb is a fellow at the American Enterprise Institute, a physician, and a thoughtful student of the intersection of medicine and government in America.
He knows how valuable the FDA’s work is, but he also knows it could do a much better job of enabling more and faster medical innovation while keeping the public safe.
White House official: President Trump to name former FDA official Scott Gottlieb as agency commissioner
http://www.seattlepi.com/news/medical/article/White-House-official-President-Trump-to-name-10993342.phpWhite House official: President Trump to name former FDA official Scott Gottlieb as agency commissioner
Scott Gottlieb Source: American Enterprise InstituteSince leaving the FDA, Gottlieb has worked as an adviser to investment firms and as a fellow at the conservative-leaning American Enterprise Institute, a Washington think tank.
In his past stint at FDA, Gottlieb served as deputy commissioner for medical and scientific affairs and helped coordinate with the White House and the Department of Health and Human Services.
Scott Gottlieb, a former deputy commissioner of the U.S. Food and Drug Administration, is President Donald Trump’s choice to lead the agency, according to an emailed statement from the White House.
Gottlieb, 44, served in several senior positions at the FDA during the George W. Bush administration.
He has been the drug industry’s preferred choice for the FDA job and has worked as a consultant to some of its companies.